However, it is clear that vitamin E blocks the ROS induction/accumulation that results from MEK1 blockade during antiestrogen and/or antiprogestin treatments and that the abrogation of ROS blocks breast cancer cell death. The gene discussed is MAP2K1; the disease is breast carcinoma.